How much does ibrutinib cost in China?
Ibrutinib is a targeted therapy used to treat certain types of leukemia and lymphoma. It is a BTK inhibitor that helps inhibit the growth and spread of cancer cells by interfering with abnormal cell signaling pathways.
Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.

Ibrutinib is commonly used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mucosa-associated lymphoid tissue lymphoma (MALTlymphoma), and some other lymphoma subtypes. It has shown good efficacy in the treatment of these leukemias and lymphomas.
The main mechanism of action of ibrutinib is to prevent the signaling of abnormal B cells by inhibiting BTK enzyme. This helps reduce the growth, spread, and survival of cancer cells.
Ibrutinib is usually taken as an oral capsule once daily, preferably at the same time. Usage and dosage should be determined based on the patient's specific condition and the doctor's recommendations.
Ibrutinib has demonstrated efficacy in multiple clinical trials in the treatment of CLL, SLL and MALT lymphoma. It is often used as ongoing treatment to maintain disease control and improve the patient's quality of life.
Ibrutinib may cause some side effects, including bleeding tendencies, high blood pressure, abnormal liver function, fatigue, gastrointestinal discomfort, skin reactions, etc. However, its safety and tolerability are generally considered to be relatively good.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)